What doctors have to say about Trump’s announcement to reduce weight loss drug costs
President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday that would lower the cost of obesity drug prices for some patients on Medicare, Medicaid and the planned “TrumpRx” pharmaceutical website. Doctors spoke with CBS News about the deal. #glp1 #weightloss #trump CBS News 24/7 is the premier anchored streaming news service […]
Employers weigh rising GLP-1 cost pressures
Post Content
Man Faints in Oval Office as Trump Admin Announces Price Cuts in Weight-Loss Drugs
A man fainted in the Oval Office on Nov. 6 as the Trump administration announced sweeping price cuts to popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, starting in early 2026. Eli Lilly CEO David A. Ricks was speaking about the deal when an unidentified man behind him, wearing a black suit, white […]
Trump announces deal to lower cost of weight loss drug
President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and Zepbound to announce new costs for Medicare recipients and price reductions set to come in 2026. NBC News’ Liz Kreutz reports. For more context and news coverage of the most important stories of our day, click […]
Trump admin brings international drug pricing to Medicaid
Presented by the Coalition to Strengthen America’s Healthcare — State Medicaid programs that choose to participate in the model will be able to purchase drugs included in the pilot at prices aligned with those paid in select other countries. {beacon} Health Care The Big Story Trump admin brings international drug pricing to Medicaid A new payment model from the Centers for […]
STAT+: Seven burning questions about Trump’s big deal for cheaper weight loss drugs
WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry leaders, public health experts, and patients with a host of open questions. The administration’s agreements with Eli Lilly and Novo Nordisk center on their much-hyped GLP-1 offerings, which officials said would now be available […]
STAT+: Kennedy, a longtime pharma critic, embraces Trump deal to expand access to obesity drugs
WASHINGTON — Health secretary Robert F. Kennedy Jr. was uncharacteristically chummy with pharma executives at the White House on Thursday as he cheered the Trump administration’s plan for lowering obesity medication prices. Kennedy has railed against drugmakers in the past, and his lifestyle-focused Make America Healthy Again movement has opposed Medicare coverage of GLP-1 weight loss […]
Trump strikes deal to lower GLP-1 drug prices
US President Donald Trump on Thursday announced deals to lower the cost of weight loss drugs Wegovy and Zepbound, a move that could vastly expand access to the blockbuster medications. The agreements with pharma giants Eli Lilly and Novo Nordisk could bring the price of the GLP-1 injectables from roughly $1,350 to $149 per month. […]
Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ Deal
by Emily Kopp at CDN – President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and Novo Nordisk in a Thursday Oval Office announcement. The obesity drugs Zepbound, marketed by Lilly, and Wegovy, marketed by Novo Nordisk, will be available at slashed prices through Trump’s innovative […]
Ozempic for all — Trump the deal-maker aims to make America slim again
GLP-1 drugs make it easier to lose weight, and to avoid associated serious health problems — and President Trump’s latest deal will bring down their high costs. It’s a win-win-win.